lysine has been researched along with Vasculitis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baer, DJ; Ferrucci, L; Gebauer, SK; Novotny, JA; Semba, RD; Silber, HA; Sun, K; Talegawkar, S; Turner, R | 1 |
| Chataigneau, M; Protin, C; Ragonnet, C; Vayssettes-Courchay, C; Verbeuren, TJ | 1 |
| Bierhaus, A; Erwin, S; Haslbeck, KM; Heuss, D; Kirchner, A; Nawroth, P; Neundörfer, B; Schlötzer, U | 1 |
| Bierhaus, A; Haslbeck, KM; Haslbeck, M; Hecht, M; Heuss, D; Nawroth, P; Neundörfer, B; Pauli, E; Schleicher, E; Schlötzer-Schrehardtt, U | 1 |
1 trial(s) available for lysine and Vasculitis
| Article | Year |
|---|---|
Dietary intake of advanced glycation end products did not affect endothelial function and inflammation in healthy adults in a randomized controlled trial.
Topics: Aged; Biomarkers; Dietary Proteins; Endothelium, Vascular; Female; Follow-Up Studies; Glycation End Products, Advanced; Humans; Hyperemia; Inflammation Mediators; Lysine; Maillard Reaction; Male; Maryland; Middle Aged; Peripheral Vascular Diseases; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Risk; Severity of Illness Index; Solubility; Vascular Resistance; Vasculitis | 2014 |
3 other study(ies) available for lysine and Vasculitis
| Article | Year |
|---|---|
Cutaneous venous dysfunction studied in vivo in the LPS-treated rabbit: implication of NO in saphenous vein hyporeactivity.
Topics: Acetylcholine; Animals; Blood Pressure; Endotoxemia; Hypotension; Infusions, Intravenous; Injections, Intravenous; Lysine; Male; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Norepinephrine; Polysaccharides, Bacterial; Rabbits; Saphenous Vein; Skin; Sumatriptan; Vasculitis; Vasoconstriction; Vasodilation | 2003 |
Receptor for advanced glycation endproduct (RAGE)-mediated nuclear factor-kappaB activation in vasculitic neuropathy.
Topics: Adult; Aged; Charcot-Marie-Tooth Disease; Humans; Immunohistochemistry; Interleukin-6; Lysine; Middle Aged; NF-kappa B; Oxidative Stress; Peripheral Nervous System Diseases; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Sural Nerve; Vasculitis | 2004 |
Activation of the RAGE pathway: a general mechanism in the pathogenesis of polyneuropathies?
Topics: Aged; Alcoholism; Biomarkers; Biopsy; Diabetes Complications; Humans; Leukocytes, Mononuclear; Lysine; Middle Aged; Peripheral Nerves; Polyneuropathies; Predictive Value of Tests; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Schwann Cells; Signal Transduction; Sural Nerve; Transcription Factor RelA; Vasculitis; Vitamin B 12 Deficiency | 2007 |